Title: Shultz MD, et al. Identification of NVP-TNKS656: the use of structure-efficiency relationships to generate a highly potent, selective, and orally active tankyrase inhibitor. J Med Chem. 2013 Aug 22;56(16):6495-511.
142166-00-5 | Methyl 3-oxo-2,4-dihydro-1,4-benzoxazine-7-carboxylate | AA001HSQ | MFCD07774184
1437-15-6 | 1,2-Bis(2-pyridyl)ethylene | AA001I4S | MFCD00006356
1440-61-5 | 2-Chloro-1-(morpholin-4-yl)ethanone | AA001IPB | MFCD00721939
1443110-01-7 | [(3-Bromocyclobutoxy)methyl]benzene | AA001J7V | MFCD21756709
144550-76-5 | Methyl 2-amino-4-iodobenzoate | AA001JNY | MFCD13182440
1447972-26-0 | (S)-Methyl morpholine-3-carboxylate-hcl | AA001K3G | MFCD09910333
145038-50-2 | Fmoc-Glu(OMe)-OH | AA001KF8 | MFCD01076132
145323-53-1 | 7-fluoroquinoxalin-2-ol | AA001KQ7 | MFCD18427201
148608-53-1 | Cytidine, 5-formyl- | AA001KZP | MFCD28342537
149105-06-6 | ((4-Bromo-3-methylphenyl)carbonyl)morpholine | AA001LB5 | MFCD09972130